London: The UK's biggest COVID-19 vaccine project, currently being tested by the University of Oxford, has shown some promising results in a small study with monkeys.
Researchers involved with the ChAdOx1 nCoV-19 trials said the vaccine had shown signs of priming the rhesus macaque monkeys’ immune systems to fend off the deadly virus and showed no indications of adverse effects.
According to the study, which is yet to be peer-reviewed, a single vaccination dose was also effective in preventing damage to the lungs – organs that can be severely affected by the virus. "A single vaccination with ChAdOx1 nCoV-19 induced a humoral and cellular immune response in rhesus macaques," the authors said. "We observed a significantly reduced viral load